Skip to main content
SpringerLink
Log in

Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis

  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

The aim of our study was to evaluate the effect of the iv administration of two different β2-receptors agonists, salbutamol and broxaterol, on the growth hormone (GH) response to maximal exercise in 11 patients (8 males and 3 females; age range 18–65 yr; mean±SE age 56±13 yr; BMI 26.2±1.4 kg/m2) with chronic asthmatic bronchitis. All the subjects underwent four cycloergometric exercise tests (incremental workload until maximal predicted heart rate). At baseline, at maximal exercise, at the end of the recovery period and 60 min after the end of each exercise, blood samples were drawn for the assay of GH, glucose, insulin, lactates, norepinephrine and epinephrine. Two exercises were performed without treatment while the remaining two were performed 60 min after the administration of 400 μg of either salbutamol or broxaterol (both diluted in 10 ml of saline) according to a randomized double blind cross-over design. Both exercise tests performed without treatment caused a significant (p<0.05) and similar GH peak with respect to baseline values (from 0.3±0.1 μg/L to 2.8±1.3 μg/L, mean of the two exercise tests). Salbutamol pretreatment blunted the GH response to exercise which caused a no more significant serum GH peak over the baseline levels (from 0.6±0.2 μg/L to 1.4±0.6 μg/L,). Moreover, broxaterol completely abolished the GH response to exercise (baseline level 0.6±0.2 μg/L; peak levels 0.4±0.1 μg/L). The serum GH peak after exercise+broxaterol was significantly (p<0.05) lower as compared to exercise+salbutamol. In conclusion, we have demonstrated for the first time that β2 stimulation blunts the physiological GH response to maximal exercise in adult human subjects. It can be suggested that changes in brain neurotransmitters, possibly an increase in the alpha-adrenergic tone, are likely to be involved in this endocrine effects of exercise.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Giustina A., Bossoni S., Licini M., Macca C., Milani G., Wehrenberg W.B. Effect of the combined administration of galanin and clonidine on serum growth hormone levels in normal subjects and in patients under chronic glucocorticoid treatment. Endocr. Res. 20: 151, 1994.

    Article  PubMed  CAS  Google Scholar 

  2. Lal S., Tolis G., Martin J.B., Braun G.M., Guyda H. Effect of clonidine on the growth hormone, luteinizing hormone, follicle stimulating hormone and thyroid stimulating hormone in the serum of normal man. J. Clin. Endocrinol. Metab. 41: 703, 1975.

    Article  Google Scholar 

  3. Giustina A., Doga M., Bossoni S., Bodini C., Legati F., Pizzocolo G., Romanelli G. Central alpha-2 adrenergic function in patients with essential hypertension. Horm. Metab. Res. 22: 451, 1990.

    Article  PubMed  CAS  Google Scholar 

  4. Mauras N., Blizzard R.M., Thorner M.O., Rogol A.D. Selective β1-adrenergic receptors blockade with atenolol enhances growth hormone-releasing hormone-mediated growth hormone release in man. Metabolism 36: 369, 1987.

    Article  PubMed  CAS  Google Scholar 

  5. Ghigo E., Bellone J., Arvat E., Mazza E., Cella S.G., Brambilla F., Muller E.E., Camanni F. Effects of alpha- and beta-adrenergic agonist and antagonist on growth hormone secretion in man. J. Neuroendocrinol. 2: 473, 1990.

    Article  PubMed  CAS  Google Scholar 

  6. Ghigo E., Arvat E., Gianotti L., Ramunni J., Maccario M., Camanni F. Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH-stimulated GH secretion in humans. Clin. Endocrinol. (Oxf) 40: 799, 1994.

    Article  CAS  Google Scholar 

  7. Giustina A., Buffoli G., Bussi A.R., Doga M.,Girelli A., Pizzoccolo G., Pozzi A., Wehrenberg W.B. Comparative effect of clonidine and growth hormone (GH)-releasing hormone on GH secretion in adult patients on chronic glucocorticoid therapy. Horm. Metab. Res. 24: 240, 1992.

    Article  PubMed  CAS  Google Scholar 

  8. Sutton J., Lazarus L. Growth hormone in exercise: comparison of physiological and pharmacological stimuli. J. Appl. Physiol. 41: 523, 1976.

    PubMed  CAS  Google Scholar 

  9. Cappa M., Grossi A., Benedetti S., Drago F., Loche S., Ghigo E. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man. J. Endocrinol. Invest. 16: 421, 1993.

    Article  PubMed  CAS  Google Scholar 

  10. American Thoracic Society Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136: 225, 1987.

    Article  Google Scholar 

  11. Ghigo E., Valette M.R., Gaggero L., Visca A., Valente F., Bellone J., Castello D., Camanni F. Therapeutical doses of salbutamol inhibit the somatotropic responiveness to growth hormone-releasing hormone in asthmatic children. J. Endocrinol. Invest. 16: 271, 1993.

    Article  PubMed  CAS  Google Scholar 

  12. Galbo H. The hormonal response to exercise. Proc. Nutr. Soc. 44: 257, 1985.

    Article  PubMed  CAS  Google Scholar 

  13. Joffe B.I., Haitas B., Eldelstein D., Panz V., Lamprey J.M., Baker S.G., Seftel H.C. Clonidine and the hormonal response to graded exercise in healthy subjects. Horm. Res. 23: 136, 1986.

    Article  PubMed  CAS  Google Scholar 

  14. Moretti C., Fabbri A., Gnessi L., Cappa M., Calzolari A., Fraioli F., Grossman A., Besser G.M. Naloxone inhibits exercise-induced release of PRL and GH in athletes. Clin. Endocrinol. (Oxf.) 18: 135, 1983.

    Article  CAS  Google Scholar 

  15. Casanueva F.F., Villanueva L., Dieguez D., Cabranes J.A., Cabezas J., Fernandez-Cruz A. Cholinergic mediation of growth hormones secretion elicited by arginine, clonidine and physical exercise in man. J. Clin. Endocrinol. Metab. 59: 526, 1984.

    Article  PubMed  CAS  Google Scholar 

  16. Felsing N.E., Brasel J.O., Cooper D.M. Effect of low and high intensity exercise on circulating growth hormone in men. J. Clin. Endocrinol. Metab. 75: 157, 1992.

    PubMed  CAS  Google Scholar 

  17. Müller E.E. The control of somatotropin secretion. Horm. Protein Peptides 7: 123, 1979.

    Google Scholar 

  18. Giustina A., Buffoli M.G., Ferrari C., Gazzoli N., Pizzocolo G., Tassi C., Wehrenberg W.B. Acute effect of propranolol on the growth-hormone (GH) response to GH releasing hormone in patients with hyperthyroidism. Horm. Metab. Res. 23: 461, 1991.

    Article  Google Scholar 

  19. Perkins S.N., Evans W.S., Thorner M.O., Cronin M.J. Beta adrenergic stimulation of growth hormone release from perifused rat anterior pituitary cells. Neuroendocrinology 37: 473, 1983.

    Article  PubMed  CAS  Google Scholar 

  20. Krieg R.J., Perkins S.N., Johnson J.H., Rogers J.P., Arimura A., Cronin M.J. β-adrenergic Stimulation of growth hormone (GH) release in vivo and subsequent inhibition of GH releasing factor-induced GH secretion. Endocrinology 22: 531, 1988.

    Article  Google Scholar 

  21. Richardson S.B., Twente S. Inhibition of hypothalamic somatostatin release by β adrenergic antagonists. Endocrinology 126: 1043, 1990.

    Article  PubMed  CAS  Google Scholar 

  22. Kelijman M., Frohman L.A. β-Adrenergic modulation of growth hormone (GH)-autofeedback on sleep associated and pharmacologically induced GH secretion. J. Clin. Endocrinol. Metab. 69: 1187, 1989.

    Article  PubMed  CAS  Google Scholar 

  23. Giustina A., Bossoni S., Bodini C., Cimino A., Pizzocolo G., Schettino M., Wehrenberg W.B. Effects of exogenous growth hormone pretreatment on the pituitary growth hormone response to growth hormone releasing hormone alone or in combination with pyridostigmine in type I diabetic patients. Acta Endocrinol. (Copenh.) 125: 510, 1991.

    CAS  Google Scholar 

  24. Lanes R., Duran Z., Aguirre J., Espina L, Alvarez W., Villaroel O., Zdanowicz M. Short- and long-term effect of oral salbutamol on growth hormone secretion in prepubertal asthmatic children. Metabolism 44: 149, 1995.

    Article  PubMed  CAS  Google Scholar 

  25. Giustina A., Bossoni S., Bodini C., Girelli A., Balestrieri G.P., Pizzocolo G., Wehrenberg W.B. Arginine normalizes the growth hormone (GH) response to GH-releasing hormone in adult patients receiving chronic daily immunosuppressive glucocorticoid therapy. J. Clin. Endocrinol. Metab. 74: 1301, 1992.

    PubMed  CAS  Google Scholar 

  26. Giustina A., Licini M., Bussi A.R., Girelli A., Pizzocolo G., Schettino M., Negro-Vilar A. Effects of sex and age on the growth hormone response to galanin in healthy human subjects. J. Clin. Endocrinol. Metab. 76: 1369, 1993

    PubMed  CAS  Google Scholar 

  27. Maki T., Kontula K., Harkonen M. The beta-adrenergic system in man: physiological and pathophysiological response. Regulation of receptor density and functioning. Scand J. Clin Lab. Invest. 50 (Suppl. 201): 25, 1990.

    Article  CAS  Google Scholar 

  28. Rampulla C., Corsico R., Majani V., Lodoia E. Broxaterol a double-blind clinical trial comparing broxaterol and salbutamol. Respiration 47: 299, 1985.

    Article  PubMed  CAS  Google Scholar 

  29. Cappon J.P., Ipp E., Brasel J.O., Cooper D.M. Acute effects of high fat and high glucose meals on the growth hormone response to exercise. J. Clin. Endocrinol. Metab. 76: 1418, 1993.

    PubMed  CAS  Google Scholar 

  30. Luger A., Watskinger B., Deuster P., Svoboda T., Clodie M., Chrousos G.P. Plasma growth hormone and prolactin responses to graded levels of acute exercise and to a lactate infusion. Neuroendocrinology 56: 112, 1992.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Dipartimento di Medicina Interna, University of Brescia, Brescia, Italy

    Andrea Giustina, M. Malerba, E. Bresciani, P. Desenzani, M. Licini, G. Zaltieri & V. Grassi

Authors
  1. Andrea Giustina
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. Malerba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E. Bresciani
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P. Desenzani
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. M. Licini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. G. Zaltieri
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. V. Grassi
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giustina, A., Malerba, M., Bresciani, E. et al. Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis. J Endocrinol Invest 18, 847–852 (1995). https://doi.org/10.1007/BF03349831

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03349831

Key-words

Search

Navigation